# Bionik Laboratories Corp. (BNKL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BNKL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 1.95M | $ -5.48M | $ -3.55M | $ 2.41M | $ -1.64M |
| 2022 | $ 1.42M | $ -17.78M | $ -4.65M | $ 0 | $ 2.93M |
| 2021 | $ 1.42M | $ -16.19M | $ -5.50M | $ 3.72M | $ 3.28M |
| 2020 | $ 2.74M | $ -31.87M | $ -11.75M | $ 2.08M | $ 13.32M |
| 2019 | $ 4.19M | $ -13.63M | $ -12.05M | $ 0 | $ 27.41M |
| 2018 | $ 1.30M | $ -19.32M | $ -10.21M | N/A | $ 20.46M |
| 2017 | $ 771.8K | $ -5.30M | $ -9.65M | $ 2.58M | $ 23.19M |
| 2016 | $ 0 | $ -7.38M | $ -6.67M | $ 0 | $ 263.9K |
| 2015 | $ 6.3K | $ -1.79M | $ -1.38M | $ 0 | $ 5.88M |
| 2014 | $ 7.8K | $ -15.7K | $ -15.7K | $ 0 | $ -10.7K |
| 2013 | $ 10.2K | $ -14.7K | $ -15.1K | $ 0 | $ 417 |
| 2012 | $ 9.4K | $ -7.8K | $ -7.0K | $ 6.0K | $ 4.2K |
| 2011 | $ 5.1K | $ -8.6K | $ -1.8K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.47 |
| Liabilities / Eq | -3.05 |
| Current Ratio | 1.20 |

## Other views

- [Metrics](https://sponda.capital/en/BNKL.md)
- [Charts](https://sponda.capital/en/BNKL/charts.md)
- [Compare](https://sponda.capital/en/BNKL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.
